Response

Affiliations

¹ Centre for Clinical Epidemiology, Lady Davis Institute - Jewish General Hospital, Montreal, QC, Canada; Department of Epidemiology and Biostatistics and Department of Medicine, McGill University, Montreal, QC, Canada. Electronic address: samy.suissa@mcgill.ca.
² Centre for Clinical Epidemiology, Lady Davis Institute - Jewish General Hospital, Montreal, QC, Canada; Department of Epidemiology and Biostatistics and Department of Medicine, McGill University, Montreal, QC, Canada.

Comment

Samy Suissa et al. Chest. 2020 May.

. 2020 May;157(5):1395-1396.

doi: 10.1016/j.chest.2020.02.022.

¹ Centre for Clinical Epidemiology, Lady Davis Institute - Jewish General Hospital, Montreal, QC, Canada; Department of Epidemiology and Biostatistics and Department of Medicine, McGill University, Montreal, QC, Canada. Electronic address: samy.suissa@mcgill.ca.
² Centre for Clinical Epidemiology, Lady Davis Institute - Jewish General Hospital, Montreal, QC, Canada; Department of Epidemiology and Biostatistics and Department of Medicine, McGill University, Montreal, QC, Canada.

No abstract available

Comment on

Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD: Cohort Study in Real-World Clinical Practice.
Suissa S, Dell'Aniello S, Ernst P. Suissa S, et al. Chest. 2020 Apr;157(4):846-855. doi: 10.1016/j.chest.2019.11.007. Epub 2019 Nov 22. Chest. 2020. PMID: 31759966
Different ICSs and the Risk of Pneumonia.
Wang CY, Wang YH, Lai CC. Wang CY, et al. Chest. 2020 May;157(5):1395. doi: 10.1016/j.chest.2019.12.051. Chest. 2020. PMID: 32386644 No abstract available.